|
Volumn 79, Issue 4, 2001, Pages 370-373
|
Interferon-alfa treatment of facial infantile haemangiomas. With emphasis on the sight-threatening varieties. A clinical series
|
Author keywords
Amblyopia; Eye at risk; Haemangiomas of the face; Induced refractive change; Infancy; Interferon alfa; Ultrasound imaging
|
Indexed keywords
PREDNISONE;
RECOMBINANT ALPHA2B INTERFERON;
ARTICLE;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG TOLERABILITY;
ECHOGRAPHY;
ENDOTHELIUM;
EVALUATION;
EYELID;
FEMALE;
FLU LIKE SYNDROME;
FOLLOW UP;
GENERAL ANESTHESIA;
GLOTTIS;
HEMANGIOMA;
HUMAN;
INFANT;
MALAISE;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPHTHALMOLOGY;
ORBIT;
PARALYSIS;
PRIORITY JOURNAL;
TUMOR GROWTH;
TUMOR LOCALIZATION;
TUMOR REGRESSION;
ANTINEOPLASTIC AGENTS;
DRUG THERAPY, COMBINATION;
EYELID NEOPLASMS;
FACIAL NEOPLASMS;
FEMALE;
HEMANGIOMA, CAPILLARY;
HUMANS;
INFANT;
INFANT, NEWBORN;
INJECTIONS, SUBCUTANEOUS;
INTERFERON-ALPHA;
MALE;
ORBITAL NEOPLASMS;
PREDNISONE;
TREATMENT OUTCOME;
|
EID: 0034922453
PISSN: 13953907
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1600-0420.2001.079004370.x Document Type: Article |
Times cited : (30)
|
References (10)
|